These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31409167)

  • 1. Villous Morphology in Urinary Bladder Biopsy: An Approach to Diagnosis.
    Mitra S; Ayyanar P; Kaur G
    Int J Surg Pathol; 2020 Feb; 28(1):4-12. PubMed ID: 31409167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial tumors with villous morphology: Histomorphology and role of immunohistochemistry in diagnosis.
    Mitra S; Chatterjee D; Das A; Gupta K; Radotra BD; Mandal AK
    APMIS; 2018 Mar; 126(3):191-200. PubMed ID: 29399882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
    Seibel JL; Prasad S; Weiss RE; Bancila E; Epstein JI
    Hum Pathol; 2002 Feb; 33(2):236-41. PubMed ID: 11957151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
    Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG
    J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the colon and urinary bladder: A fortuitous or an embryological phenomenon?
    Nambiyar K; Mitra S; Das A; Bal A
    Indian J Pathol Microbiol; 2021; 64(1):132-135. PubMed ID: 33433423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor lesions of the urinary bladder.
    McKenney JK
    Histopathology; 2019 Jan; 74(1):68-76. PubMed ID: 30565304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma.
    So JS; Epstein JI
    Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification of urinary bladder tumors].
    Andreeva IuIu; Zavalishina LE; Frank GA
    Arkh Patol; 2006; 68(5):46-53. PubMed ID: 17144533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.
    Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB
    Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Villous adenoma of the bladder.
    Tripodi SA; Laurini L; Presenti L; Brunettini C; Boncompagni G; Messina M; D'Agata A; Del Vecchio MT
    Minerva Urol Nefrol; 1997 Sep; 49(3):169-71. PubMed ID: 9396223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glandular lesions of the urinary bladder:clinical significance and differential diagnosis.
    Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
    Histopathology; 2011 May; 58(6):811-34. PubMed ID: 20854477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Villous Adenoma Arising in the Native Bladder Mucosa and the Upper Urinary Tract With Coexisting Neuroendocrine Carcinoma Following Augmentation Cystoplasty.
    Nayak A; Depasquale B; Vergara N; Guzzo TA; Lal P
    Int J Surg Pathol; 2019 Jun; 27(4):450-456. PubMed ID: 30701999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance.
    Zhong M; Gersbach E; Rohan SM; Yang XJ
    Arch Pathol Lab Med; 2013 Mar; 137(3):371-81. PubMed ID: 23451748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation.
    Xu H; Genega EM; Zhuang L; Zhou M
    Int J Surg Pathol; 2021 Oct; 29(7):794-797. PubMed ID: 33733892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial carcinoma with villoglandular differentiation: a study of 14 cases.
    Lim M; Adsay NV; Grignon D; Osunkoya AO
    Mod Pathol; 2009 Oct; 22(10):1280-6. PubMed ID: 19593329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
    Rao Q; Williamson SR; Lopez-Beltran A; Montironi R; Huang W; Eble JN; Grignon DJ; Koch MO; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Cheng L
    Mod Pathol; 2013 May; 26(5):725-32. PubMed ID: 23348900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.